Anti-semaphorin 3A antibodies

US12384843B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Dorian Schönfeld · Cologne, DE
• Karoline Dröbner · Wuppertal, DE
• Ernst Weber · Langenfeld, DE
• Katharina Filarsky · Düsseldorf, DE
• Philipp Ellinger · Düsseldorf, DE
• Fionnuala Mary McAleese Eser · Langenfeld, DE
• Ingo Flamme · Bergneustadt, DE
• Winfried Wunderlich · Bovenden, DE
• Antje Schmidt · Göttingen, DE
• Yalda Sedaghat · Hamburg, DE
• Kenneth Young · Hamburg, DE

Key dates

• Filing date: Mar 28, 2022
• Grant date: Aug 12, 2025
• Expiry date: Mar 28, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to an isolated antibody or antigen-binding fragment thereof that binds to human Semaphorin 3A (Sema3A). An antibody conjugate and a pharmaceutical composition each comprising the isolated antibody or antigen-binding fragment thereof that binds to human Sema3A are also provided.